NYSEARCA:AEON - NYSE Arca - US00791X1000 - Common Stock - Currency: USD
NYSEARCA:AEON (2/21/2025, 11:32:49 AM)
0.1075
+0 (+0.19%)
The current stock price of AEON is 0.1075 USD. In the past month the price decreased by -13.88%. In the past year, price decreased by -99.06%.
AEON Biopharma is a biopharmaceutical company focused on the development of ABP-450, a proprietary 900 kDabotulinum toxin complex, for debilitating medical conditions. The company is headquartered in Newport Beach, California and currently employs 6 full-time employees. The company went IPO on 2021-10-08. The firm is focused on developing botulinum toxin complex, ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions. The biologic ingredient in ABP-450 is Clostridium botulinum toxin, type A with a molecular weight of 900 kDa. Its initial development programs for ABP-450 are focused on migraine, cervical dystonia and gastroparesis. Migraine is a neurological condition characterized by recurrent episodes of headaches. The firm is developing ABP-450 for the preventative treatment of migraine, which is inclusive of both chronic migraine and episodic migraine. Cervical dystonia is a neurological condition characterized by involuntary muscle contractions of the neck which may present as spasms, contractions or abnormal posture. Gastroparesis is a gastrointestinal disorder characterized by the slowing or stoppage of movement of food and liquid from the stomach to the small intestine.
AEON BIOPHARMA INC
4040 Macarthur Boulevard, Suite 310
Newport Beach CALIFORNIA US
Employees: 5
Company Website: https://www.aeonbiopharma.com/
Investor Relations: https://investors.aeonbiopharma.com/overview/default.aspx
Phone: 19492844555.0
The current stock price of AEON is 0.1075 USD. The price increased by 0.19% in the last trading session.
The exchange symbol of AEON BIOPHARMA INC is AEON and it is listed on the NYSE Arca exchange.
AEON stock is listed on the NYSE Arca exchange.
7 analysts have analysed AEON and the average price target is 5.1 USD. This implies a price increase of 4644.19% is expected in the next year compared to the current price of 0.1075. Check the AEON BIOPHARMA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
AEON BIOPHARMA INC (AEON) has a market capitalization of 3.99M USD. This makes AEON a Nano Cap stock.
AEON BIOPHARMA INC (AEON) currently has 5 employees.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
AEON does not pay a dividend.
AEON BIOPHARMA INC (AEON) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.56).
The outstanding short interest for AEON BIOPHARMA INC (AEON) is 27.32% of its float. Check the ownership tab for more information on the AEON short interest.
ChartMill assigns a fundamental rating of 1 / 10 to AEON. AEON may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months AEON reported a non-GAAP Earnings per Share(EPS) of -0.56. The EPS decreased by -409.61% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -116.07% | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 83% to AEON. The Buy consensus is the average rating of analysts ratings from 7 analysts.